{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:42:35Z","timestamp":1792701755817,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Impact of pneumococcal conjugate vaccines (PCVs) on pneumococcal disease is well described; pneumococcus is infrequently identified by culture in pneumonia. Yield is higher when pleural fluid is cultured. Polymerase chain reaction (PCR) in pleural fluid samples improves pathogen identification, particularly in the case of <jats:italic toggle=\"yes\">S. pneumoniae.<\/jats:italic>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Healthy children with empyema who underwent pleural fluid drainage were eligible. Demographics and PCV immunization status were collected. Blood\/pleural fluid cultures were obtained. Pleural fluid samples were sent for PCR for pathogen. Serotyping was done by Neufeld-Quellung reaction on pneumococcus isolates, and PCR in culture negative cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From December 2018 to September 2023, 74 patients were enrolled. Pathogens were cultured in 22 patients (29.7%), with pneumococcus found in 6 (27.3%). PCR identified additional pathogens in 23 patients (31.1%), including 18 pneumococci (81.8%) and real-time PCR identified 5 more pneumococci, totaling 29 pneumococci, with 23 (79.3%) detected by PCR only. Serotype information was available for 27 (93.1%) pneumococci; 22 (81.5%) were identified as PCV-13 serotypes, with serotype 3 being present in 17 (63%) cases. Among patients with a PCV-13 serotype detected through culture or molecular methods, 15 (68.2%) were fully vaccinated with PCV-13, including 11 of 17 (65%) with serotype 3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>, particularly serotype 3, is the leading bacterial pathogen in children \u226418 years old. Molecular diagnosis enhances pathogen detection. Ongoing surveillance is crucial to monitor etiology changes as new pneumococcal vaccines are introduced.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004833","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T13:00:26Z","timestamp":1745240426000},"page":"622-629","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Parapneumonic Empyema Complicating Community-acquired Pneumonia: Etiology in the Era of Pneumococcal Vaccination and Role of Molecular Diagnosis"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9281-8915","authenticated-orcid":false,"given":"Antonio C.","family":"Arrieta","sequence":"first","affiliation":[{"name":"Department of Pediatric Infectious Disease, Children\u2019s Hospital of Orange County, Orange, California"},{"name":"University of California at Irvine, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7050-6275","authenticated-orcid":false,"given":"Stephanie","family":"Osborne","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease, Children\u2019s Hospital of Orange County, Orange, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-6424","authenticated-orcid":false,"given":"Lindsay R.","family":"Grant","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-7194","authenticated-orcid":false,"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-3007","authenticated-orcid":false,"given":"Anne J.","family":"Blaschke","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7446-157X","authenticated-orcid":false,"given":"Kristina G.","family":"Hulten","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-7111","authenticated-orcid":false,"given":"Delma J.","family":"Nieves","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease, Children\u2019s Hospital of Orange County, Orange, California"},{"name":"University of California at Irvine, Irvine, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-5967","authenticated-orcid":false,"given":"Ashley","family":"Miller","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Bender","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-2412","authenticated-orcid":false,"given":"Raul","family":"Isturiz","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-7467","authenticated-orcid":false,"given":"Ronika","family":"Alexander","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4895-6031","authenticated-orcid":false,"given":"Shannon M.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Lamberth","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-6862","authenticated-orcid":false,"given":"Alejandro","family":"Cane","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Arguedas","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"R1-20250613","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"17","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R2-20250613","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/clinids\/22.6.1057","article-title":"Pneumococcal pleural empyemas in children.","volume":"22","author":"Hardie","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R3-20250613","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R4-20250613","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.inf.0000202137.37642.ab","article-title":"Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.","volume":"25","author":"Byington","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250613","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/thx.2003.016105","article-title":"Clinical features, aetiology and outcome of empyema in children in the north east of England.","volume":"59","author":"Eastham","year":"2004","journal-title":"Thorax"},{"key":"R6-20250613","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1542\/peds.2017-1013","article-title":"Utility of blood culture among children hospitalized with community-acquired pneumonia.","volume":"140","author":"Neuman","year":"2017","journal-title":"Pediatrics"},{"key":"R7-20250613","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/INF.0000000000001940","article-title":"Blood culture and pleural fluid culture yields in pediatric empyema patients: a retrospective review, 1996-2016.","volume":"37","author":"Stankey","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250613","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","article-title":"Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.","volume":"30","author":"Blaschke","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20250613","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/INF.0b013e3182784ec1","article-title":"Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture.","volume":"32","author":"Blaschke","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250613","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cid\/ciae439","article-title":"Clinical impact of pleural fluid Streptococcus pneumoniae PCR testing in children with complicated pneumonia.","volume":"79","author":"Ho","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2016.05.009","article-title":"Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.","volume":"116","author":"Krenke","year":"2016","journal-title":"Respir Med"},{"key":"R12-20250613","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.07.022","article-title":"Pleural effusion with negative culture: a challenge for pneumococcal diagnosis in children.","volume":"86","author":"Perez","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R13-20250613","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/JCM.00603-12","article-title":"Rapid detection of Streptococcus pyogenes in pleural fluid samples from pediatric patients with empyema.","volume":"50","author":"Zheng","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"3 Pt 1","key":"R14-20250613","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children\u2019s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"R15-20250613","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"R17-20250613","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"R18-20250613","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/586747","article-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter?","volume":"46","author":"Bender","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"RR-11","key":"R19-20250613","first-page":"1","article-title":"Prevention, Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Nuorti","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R20-20250613","first-page":"253","article-title":"Prevention, invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20250613","article-title":"United States Census Bureau.","year":"2018"},{"key":"R22-20250613","doi-asserted-by":"crossref","first-page":"063039","DOI":"10.1542\/peds.2023-063039","article-title":"Invasive pneumococcal disease after 2 decades of pneumococcal conjugate vaccine use.","volume":"153","author":"Yildirim","year":"2024","journal-title":"Pediatrics"},{"key":"R23-20250613","doi-asserted-by":"crossref","first-page":"e0189122","DOI":"10.1128\/jcm.01891-22","article-title":"Multicenter evaluation of the BIOFIRE blood culture identification 2 panel for detection of bacteria, yeasts, and antimicrobial resistance genes in positive blood culture samples.","volume":"61","author":"Rhoads","year":"2023","journal-title":"J Clin Microbiol"},{"key":"R24-20250613","doi-asserted-by":"crossref","first-page":"675225","DOI":"10.3389\/fmed.2021.675225","article-title":"Bacterial spectrum of spontaneously ruptured otitis media in a 7-year, longitudinal, multicenter, epidemiological cross-sectional study in Germany.","volume":"8","author":"Im\u00f6hl","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R25-20250613","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2019.10.056","article-title":"Increase in streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion\/empyema after the introduction of PCV13 in Germany.","volume":"38","author":"Goettler","year":"2020","journal-title":"Vaccine"},{"key":"R26-20250613","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/INF.0000000000002474","article-title":"Increasing rates of pediatric empyema and disease severity with predominance of serotype 3 S. pneumonia: an Australian single-center, retrospective cohort 2011 to 2018.","volume":"38","author":"Haggie","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20250613","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3201\/eid2606.190951","article-title":"Failures of 13-valent conjugated pneumococcal vaccine in age-appropriately vaccinated children 2-59 months of age, Spain.","volume":"26","author":"Hernandez","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R28-20250613","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cid\/ciz221","article-title":"Changes in invasive pneumococcal disease spectrum after 13-valent pneumococcal conjugate vaccine implementation.","volume":"70","author":"Levy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R29-20250613","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jpids\/piy103","article-title":"Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation.","volume":"8","author":"Madhi","year":"2019","journal-title":"J. Pediatric Infect. Dis. Soc"},{"key":"R30-20250613","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study.","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R31-20250613","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1093\/cid\/ciz1164","article-title":"Dose-specific effectiveness of 7- and 13-valent pneumococcal conjugate vaccines against vaccine-serotype streptococcus pneumoniae colonization in children.","volume":"71","author":"Lewnard","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R32-20250613","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R33-20250613","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/INF.0000000000004418","article-title":"Epidemiology and management of pediatric group A streptococcal pneumonia with parapneumonic effusion: an observational study.","volume":"43","author":"Lees","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20250613","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jinf.2018.06.004","article-title":"The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis.","volume":"77","author":"Balsells","year":"2018","journal-title":"J Infect"},{"key":"R35-20250613","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20250613","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era.","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R37-20250613","doi-asserted-by":"crossref","first-page":"0567","DOI":"10.1542\/peds.2019-0567","article-title":"Invasive pneumococcal disease in children\u2019s hospitals: 2014-2017.","volume":"144","author":"Kaplan","year":"2019","journal-title":"Pediatrics"},{"key":"R38-20250613","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/cid\/ciab066","article-title":"Effectiveness of the 7- and 13-valent pneumococcal conjugate vaccines against vaccine-serotype otitis media.","volume":"73","author":"Dagan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R39-20250613","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciy920","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of observational studies.","volume":"68","author":"Sings","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R40-20250613","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/pathogens9050396","article-title":"Characteristics of serotype 3 invasive pneumococcal disease before and after universal childhood immunization with PCV13 in Massachusetts.","volume":"9","author":"Lapidot","year":"2020","journal-title":"Pathogens"},{"key":"R41-20250613","doi-asserted-by":"crossref","first-page":"e0107722","DOI":"10.1128\/spectrum.01077-22","article-title":"Continued vaccine breakthrough cases of serotype 3 complicated pneumonia in vaccinated children, Portugal (2016-2019).","volume":"10","author":"Silva-Costa","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R42-20250613","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/INF.0000000000002765","article-title":"A phase II trial of safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in healthy infants.","volume":"39","author":"Platt","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R43-20250613","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/INF.0000000000003277","article-title":"Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy infants in the United States.","volume":"40","author":"Senders","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R44-20250613","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R45-20250613","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1016\/j.vaccine.2023.07.049","article-title":"Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada.","volume":"41","author":"Deceuninck","year":"2023","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:05:06Z","timestamp":1749852306000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004833","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}